UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller

PloS one, 2012-02, Vol.7 (2), p.e31928-e31928

2012

Volltextzugriff (PDF)

HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds

Current medicinal chemistry, 2014-01, Vol.21 (2), p.238-250

2014

Volltextzugriff (PDF)

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure

Scientific reports, 2020-02, Vol.10 (1), p.1902-11, Article 1902

2020

Volltextzugriff (PDF)

Second-Site Reversion of a Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant That Restores Enzyme Function and Replication Capacity

Journal of Virology, 1999-08, Vol.73 (8), p.6293-6298

1999

Volltextzugriff (PDF)

Definition of the viral targets of protective HIV-1-specific T cell responses

Journal of translational medicine, 2011-12, Vol.9 (1), p.208-208, Article 208

2011

Volltextzugriff (PDF)

Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity

Nanomedicine, 2017-02, Vol.13 (2), p.601-609

2017

Volltextzugriff (PDF)

Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant

PloS one, 2018-12, Vol.13 (12), p.e0208345-e0208345

2018

Volltextzugriff (PDF)

Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 Envelope

Vaccines (Basel), 2022-03, Vol.10 (4), p.484

2022

Volltextzugriff (PDF)

The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios

Vaccines (Basel), 2023-12, Vol.12 (1), p.8

2023

Volltextzugriff (PDF)

HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity

PloS one, 2015-08, Vol.10 (8), p.e0134054-e0134054

2015

Volltextzugriff (PDF)

Evolution of Broadly Cross-Reactive HIV-1-Neutralizing Activity: Therapy-Associated Decline, Positive Association with Detectable Viremia, and Partial Restoration of B-Cell Subpopulations

Journal of Virology, 2013-11, Vol.87 (22), p.12227-12236

2013

Volltextzugriff (PDF)

Antibody-Based Preventive and Therapeutic Strategies Against HIV

Current HIV research, 2016-05, Vol.14 (3), p.260-269

2016

Volltextzugriff (PDF)

Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage

PloS one, 2010-09, Vol.5 (9), p.e12926-e12926

2010

Volltextzugriff (PDF)

Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral Therapy

Journal of Virology, 2009-10, Vol.83 (19), p.9731-9742

2009

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 and Related Primate Lentiviruses Engage Clathrin through Gag-Pol or Gag

Journal of Virology, 2011-04, Vol.85 (8), p.3792-3801

2011

Volltextzugriff (PDF)

Influenza, but not HIV‐specific CTL epitopes, elicits delayed‐type hypersensitivity (DTH) reactions in HIV‐infected patients

European journal of immunology, 2013-06, Vol.43 (6), p.1545-1554

2013

Volltextzugriff (PDF)

Identification and Characterization of HIV-1 CD8+ T Cell Escape Variants with Impaired Fitness

The Journal of infectious diseases, 2008-01, Vol.197 (2), p.300-308

2008

Volltextzugriff (PDF)

Resistance to Nucleoside Analog Reverse Transcriptase Inhibitors Mediated by Human Immunodeficiency Virus Type 1 p6 Protein

Journal of Virology, 2001-10, Vol.75 (20), p.9644-9653

2001

Volltextzugriff (PDF)

Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses

Journal of virology, 2022-01, Vol.96 (1), p.e0134321-e0134321

2022

Volltextzugriff (PDF)

HIV-1-Specific CD8+ T Cell Responses and Viral Evolution in Women and Infants

The Journal of immunology (1950), 2005-11, Vol.175 (10), p.6976-6986

2005

Volltextzugriff (PDF)

Genetic analysis of culture-negative UNAIDS subtype C samples

AIDS research and human retroviruses, 2003, Vol.19 (1), p.49-55

2003

Volltextzugriff (PDF)

Genetic changes associated with distinct patterns of HIV type 1 persistence in chronically infected cell lines

AIDS research and human retroviruses, 2007-02, Vol.23 (2), p.251-260

2007

Volltextzugriff (PDF)

HIV-1-Specific CD8 super(+) T Cell Responses and Viral Evolution in Women and Infants

Journal of Immunology, 2005-11, Vol.175 (10), p.6976-6986

2005

Volltextzugriff (PDF)

HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity: e0134054

PloS one, 2015-08, Vol.10 (8)

2015

Volltextzugriff (PDF)

Status of transition care in inflammatory bowel disease in Spain. Different medical perspectives

Revista española de enfermedades digestivas, 2019-11, Vol.111 (11), p.833-838

2019

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller

HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure

Second-Site Reversion of a Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant That Restores Enzyme Function and Replication Capacity

Definition of the viral targets of protective HIV-1-specific T cell responses

Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity

Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant

Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 Envelope

The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios

HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity

Evolution of Broadly Cross-Reactive HIV-1-Neutralizing Activity: Therapy-Associated Decline, Positive Association with Detectable Viremia, and Partial Restoration of B-Cell Subpopulations

Antibody-Based Preventive and Therapeutic Strategies Against HIV

Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage

Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral Therapy

Human Immunodeficiency Virus Type 1 and Related Primate Lentiviruses Engage Clathrin through Gag-Pol or Gag

Influenza, but not HIV‐specific CTL epitopes, elicits delayed‐type hypersensitivity (DTH) reactions in HIV‐infected patients

Identification and Characterization of HIV-1 CD8+ T Cell Escape Variants with Impaired Fitness

Resistance to Nucleoside Analog Reverse Transcriptase Inhibitors Mediated by Human Immunodeficiency Virus Type 1 p6 Protein

Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses

HIV-1-Specific CD8+ T Cell Responses and Viral Evolution in Women and Infants

Genetic analysis of culture-negative UNAIDS subtype C samples

Genetic changes associated with distinct patterns of HIV type 1 persistence in chronically infected cell lines

HIV-1-Specific CD8 super(+) T Cell Responses and Viral Evolution in Women and Infants

HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity: e0134054

Status of transition care in inflammatory bowel disease in Spain. Different medical perspectives

Suchergebnisse filtern